Ulysses Management’s CVS Health CVS Stock Holding History

Ulysses Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$3.99M	–	59
2024 Q1	$3.99M	Buy	50,000 +10,000	+25%	+$764K	0.34%	30
2023 Q4	$3.16M	Buy	+40,000	New	+$2.85M	0.28%	33
2021 Q4	–	Sell	-20,000	Closed	-$1.7M	–	61
2021 Q3	$1.7M	Sell	20,000 -12,000	-38%	-$1.01M	0.18%	39
2021 Q2	$2.67M	Sell	32,000 -15,000	-32%	-$1.23M	0.34%	34
2021 Q1	$3.54M	Buy	47,000 +7,000	+18%	+$510K	0.38%	37
2020 Q4	$2.73M	Sell	40,000 -10,000	-20%	-$650K	0.49%	32
2020 Q3	$2.92M	Buy	50,000 +5,000	+11%	+$311K	0.32%	34
2020 Q2	$2.92M	Buy	45,000 +20,000	+80%	+$1.26M	0.42%	27
2020 Q1	$1.48M	Buy	+25,000	New	+$1.67M	0.3%	27
2019 Q4	–	Sell	-40,000	Closed	-$2.52M	–	49
2019 Q3	$2.52M	Hold	40,000	–	–	0.23%	34
2019 Q2	$2.18M	Buy	40,000 +20,000	+100%	+$1.08M	0.19%	39
2019 Q1	$1.08M	Buy	+20,000	New	+$1.23M	0.1%	43

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ulysses Management's CVS Position: Q2 2024 in Review

Ulysses Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 50,000 shares — an estimated $3.99M sold.

Ulysses Management first reported a position in CVS in Q1 2019 and held it in 12 quarters. The position peaked at $3.99M in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Ulysses Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Ulysses Management sold 50,000 CVS Health shares in Q2 2024, an estimated $3.99M.
Ulysses Management first reported a position in CVS Health in Q1 2019 and held it in 12 quarters.
Ulysses Management's CVS Health position peaked at $3.99M in Q1 2024.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Ulysses Management's 13F filing for Q2 2024, filed 14 Aug 2024.